Who are Malathion gel 0.5%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Bloxiverz, Razadyne, Camptosar, Camptosar, Zantac, Flaxedil.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/malathion-gel-0-5.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Malathion gel 0.5% — Competitive Intelligence Brief

Malathion gel 0.5% (Malathion gel 0.5%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Organophosphate insecticide. Area: Dermatology / Parasitology.

phase 3 Organophosphate insecticide Acetylcholinesterase Dermatology / Parasitology Small molecule Live · refreshed every 30 min

Target snapshot

Malathion gel 0.5% (Malathion gel 0.5%) — Sun Pharmaceutical Industries, Inc.. Malathion is an organophosphate insecticide that inhibits acetylcholinesterase, causing accumulation of acetylcholine and paralysis of parasites.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Malathion gel 0.5% TARGET	Malathion gel 0.5%	Sun Pharmaceutical Industries, Inc.	phase 3	Organophosphate insecticide	Acetylcholinesterase
Bloxiverz	NEOSTIGMINE	Fresenius Kabi	marketed	Cholinesterase Inhibitor	Acetylcholinesterase	2013-01-01
Razadyne	GALANTAMINE	Johnson & Johnson	marketed	Cholinesterase Inhibitor	Acetylcholinesterase	2001-01-01
Camptosar	Irinotecan Hydrochloride	Pfizer	marketed	Topoisomerase Inhibitor	Acetylcholinesterase	1996-01-01
Camptosar	onivyde	Pfizer	marketed	Topoisomerase Inhibitor	Acetylcholinesterase	1996-01-01
Zantac	ranitidine	GSK (originally Glaxo)	marketed	H2 receptor antagonist	Multidrug and toxin extrusion protein 1, Acetylcholinesterase, Histamine H2 receptor	1983-06-01
Flaxedil	GALLAMINE	Davis And Geck	marketed	gallamine	Acetylcholine receptor subunit alpha, Acetylcholinesterase, Muscarinic acetylcholine receptor M1	1982-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2027-01-06 — Camptosar · 8329213 · US
2027-01-06 — Camptosar · 8329213 · Compound · US
2028-08-29 — Camptosar · 8147867 · Compound · US
2028-08-29 — Camptosar · 8147867 · US
2033-06-12 — Camptosar · 9364473 · US
2033-06-12 — Camptosar · 9452162 · US
2033-06-12 — Camptosar · 9492442 · US
2033-06-12 — Camptosar · 9717724 · US
2033-06-12 — Camptosar · 9717724 · Method of Use · US
2033-06-12 — Camptosar · 9364473 · Method of Use · US
2033-06-12 — Camptosar · 12364691 · Method of Use · US
2033-06-12 — Camptosar · 11369597 · Method of Use · US
2033-06-12 — Camptosar · 9339497 · Method of Use · US
2033-06-12 — Camptosar · 9452162 · Method of Use · US
2033-06-12 — Camptosar · 9492442 · Method of Use · US
2033-06-12 — Camptosar · 10980795 · US
2033-06-12 — Camptosar · 11369597 · US
2033-06-12 — Camptosar · 9339497 · US
2033-06-12 — Camptosar · 10980795 · Method of Use · US
2036-08-19 — Camptosar · 11344552 · Method of Use · US
2036-10-15 — Camptosar · 10456360 · US
2036-10-15 — Camptosar · 10993914 · US
2036-10-15 — Camptosar · 12059497 · Formulation · US
2036-10-15 — Camptosar · 10456360 · Formulation · US
2036-10-15 — Camptosar · 10993914 · Formulation · US

Sponsor landscape (Organophosphate insecticide class)

London School of Hygiene and Tropical Medicine · 1 drug in this class
Sun Pharmaceutical Industries, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Malathion gel 0.5% — Competitive Intelligence Brief. https://druglandscape.com/ci/malathion-gel-0-5. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab